安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- The New England Journal of Medicine | Research Review Articles on . . .
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
In this phase 3b, open-label, controlled trial, adult participants with obesity but without type 2 diabetes were randomly assigned in a 1:1 ratio to receive the maximum tolerated dose of
- About NEJM - The New England Journal of Medicine
With a 2023 Journal Impact Factor of 96 2, NEJM is a top-ranked, global, multi-specialty journal in the general medicine category [Source: 2023 Journal Impact Factor, Journal Citation Reports
- Current Issue | New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol 392 No 23)
- New England Journal of Medicine
The New England Journal of Medicine publishes high-quality medical research, reviews, and opinions to advance medical science and improve patient care
- Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease . . .
Targeted DNA Methylation Using Modified DNA Probes: A Potential Therapeutic Tool for Depression and Stress-Related Disorders, International Journal of Molecular Sciences, 26, 12, (5643), (2025
- Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal . . .
Tezepelumab is a human monoclonal antibody that specifically blocks TSLP from interacting with its heterodimeric receptor 21,22 Tezepelumab administered subcutaneously at a dose of 210 mg every 4
- Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Tolebrutinib is an oral, brain-penetrant, and bioactive BTK inhibitor intended to target disease-associated microglia and B cells within the CNS in addition to their counterparts in the periphery
|
|
|